Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    ORAL 33 - ALK

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:S. Gadgeel
    • Coordinates: 9/09/2015, 16:45 - 18:15, Mile High Ballroom 1a-1f
    • +

      ORAL33.02 - Time to Progression and Post-Progression Survival in ALK+ Ceritinib-Treated NSCLC

      16:56 - 17:07  |  Author(s): G. Liu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 40 - Biology 1

    • Type: Oral Session
    • Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
    • Presentations: 8
    • Moderators:C. Brambilla
    • Coordinates: 9/09/2015, 16:45 - 18:15, 702+704+706
    • +

      ORAL40.01 - PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1+ Lymphocytes within Malignant Effusions Induce PD-L1 Expression

      16:45 - 16:56  |  Author(s): S. Khanna

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 31 - ALK

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:S. Malik
    • Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 1a-1f
    • +

      MINI31.01 - Diverse Characteristics of ALK+ NSCLC Patients in the United States

      18:30 - 18:35  |  Author(s): E. Bendaly

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MINI31.02 - Real-World Characteristics and Outcomes for ALK+ NSCLC in Korea

      18:35 - 18:40  |  Author(s): S.H. Lim

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MINI31.13 - Symptoms and QOL with Ceritinib in ALK+ NSCLC Patients with/without Brain Metastases

      19:40 - 19:45  |  Author(s): L. Crinò

      • Abstract

      Loading...

    • +

      MINI31.14 - PROs with Ceritinib in ALKi-Naive ALK+ NSCLC Patients with and without Brain Metastases

      19:45 - 19:50  |  Author(s): K. Park

      • Abstract

      Loading...